- Bachelor of Science: Northwest Missouri State
University
- DVM: University of Missouri-Columbia
- Internship: Veterinary Specialists of
Rochester, Rochester, NY
- Residency: University of Missouri-Columbia
- MS: University of Missouri-Columbia
- Medicine II (3rd year)
- Clinical Oncology (4th year)
- Clinical trials of novel cytotoxic agents
- Gene expression of feline lymphoma
- Molecular evaluation and therapeutics of
canine lymphoma
Dr. Higginbotham’s clinical interests are
canine and feline oncology.
- Taylor KH, Smith AN,
Higginbotham ML, Schwartz DD, Carpenter DM,
Whitley EM. Expression of vascular endothelial growth factor in
canine oral malignant melanoma. Vet
Comp Oncology 2007, 5(4):197-207.
- Henry CJ, Downing S, Rosenthal RC, Klein MK, Meleo K, Villamil
JA, Fineman LS, McCaw
DL, Higginbotham ML, McMichael J. Evaluation of a novel
immunomodulator composed of
human chorionic gonadotropin and bacillus Calmette-Guerin for
treatment of canine mast cell tumors in clinically affected dogs.
Am J Vet Res.
2007, 68(11):1246-1251.
- Smith AN, Whitley E, Bird RC,
Higginbotham ML,
Smith BF. Molecular characterization of lymphoma, 27th Annual
Veterinary Cancer Society Conference, Fort Lauderdale, Florida,
November 1-4, 2007.
- Higginbotham ML,
Henry CJ, Katti KV, Casteel SW, Dowling PM,
Pillarsetty N. Preclinical tolerance
and pharmacokinetic assessment of MU-Gold, a novel chemotherapeutic
agent, in laboratory dogs. Vet Ther. 2003, 4(1):76-82.
- Henry CJ, Tyler JW, McEntee MC, Stokol T, Rogers KS, Chun R,
Garrett LD, McCaw DL,
Higginbotham ML, Glessland KA, Sotkes PK.
Evaluation of a bladder tumor antigen test as a screening test for
transitional cell carcinoma of the lower urinary tract in dogs.
Am J Vet Res.
2003, 64(8):1017-20.
|
